ImmunityBio, Inc. (IBRX) Corporate Subsidiaries
ImmunityBio, Inc. (IBRX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IBRX
CIK: 1326110
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerBruce Rucks
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | 8-K | 0001193125-26-421820 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-05 | FORM 4 | 0001326110-26-000085 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-02 | FORM 4 | 0001326110-26-000084 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001949846-26-000605 | View SEC Doc Filr Page |
| 144 | 2026-10-02 | — | 144 Filing | 0001950047-26-010013 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-06 | — | SCHEDULE 13D/A Filing | 0001193125-26-338651 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001326110-26-000079 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001326110-26-000077 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-29 | 8-K | 0001326110-26-000071 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-02 | FORM 4 | 0001529371-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | FORM 4 | 0001849739-26-000014 | View SEC Doc Filr Page |
| 144 | 2026-07-02 | — | 144 Filing | 0001950047-26-006831 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | FORM 4 | 0001849739-26-000011 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001950047-26-006714 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006655 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001950047-26-006608 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001647994-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001371407-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001364846-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001822674-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001349193-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001529371-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001849739-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-09 | 8-K | 0001326110-26-000064 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001647994-26-000008 | View SEC Doc Filr Page |